  |
Market Research in the Healthcare Field with Expertise in Medical Imaging and Radioisotopes
Bio-Tech Systems, Inc. - 4167 West Pinecrest Circle - Las Vegas, Nevada 89121 phone: (702) 456-7608 - fax: (702) 456-2189
PET Reimbursement for Alzheimer's Will Have Significant Market ImpactJan. 10, 2005
Several studies have recently employed PET to show notable changes in the brains of Alzheimer's patients. As a result, clinicians have been utilizing PET to identify those people in the earliest stages of the disease in time to slow its progression with available drugs. PET has also been used to show how well the drugs have been working. Therefore, CMS approval of PET imaging for suspected Alzheimer's patients is certain to have a major impact in the future and should bolster brain imaging volume dramatically. Major efforts are being devoted to identifying the buildup of clumps of protein (amyloid plaque) in the brain and limit this destructive process. Many promising new drugs are in development that target this plaque buildup. Vaccines are also under development that prime the body to resist amyloid plaque. Researchers are also exploring the use of embryonic stem cells that slow the rate of degeneration in Alzheimer's patients. A key research goal is to predict who will get Alzheimer's before symptoms appear. Since the disease develops over many years, much damage has been done by the time it is diagnosed. Therefore, early diagnosing and treatment may help many patients. Clinicians also want to track the progress of the disease in patients being treated, so that they can quickly determine which treatment is most effective. The challenge is to educate neurologists to the benefits of PET imaging to obtain the highest confidence level in diagnosing their patients. This is a gradual process, however, it should contribute to expanded use of PET in neurology within the near future. These potentials are discussed in detail in Bio-Tech Systems' Bio-Tech Systems' Report 200, Market for PET Radiopharmaceuticals and PET Imaging. by Marvin Burns
Jan. 10, 2005 BIO-TECH SYSTEMS, INC., founded in 1980, provides clients with market research services in the healthcare field. This focuses on strategic planning, market research and development of new business opportunities. Bio Tech specializes in product and market evaluation where technical insight is important as well as the ability to communicate with many levels of management and end-users. One objective is to assess technological risk and target new products and services effectively in order to generate the best market response. Bio-Tech's expertise is in medical imaging and radioisotope products covering a broad range of diagnostic and therapeutic applications. For further details and information, please visit us at: Related Reading:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Back to Top
Send
this page to a friend
Breaking Market News | Orders | News Releases | Contact Us
Report #310 | Report #300 | Report #290 | Report #260 | Report #230 | Top